Advertisement

Topics

Dainippon Pharmaceutical Company Limited Company Profile

02:51 EDT 30th September 2016 | BioPortfolio

Antibiotics Diagnostics Veterinary

Location

6-8 Dosho-machi 2-chome Chuo-ku
Osaka
Osaka
541
Japan

Contact

Phone: 81 6 6203 5321
Fax: 81 6 203 6581


News Articles [1997 Associated News Articles listed on BioPortfolio]

BRIEF-Otcpharm to liquidate DONELLE COMPANY LIMITED

* Decides to liquidate DONELLE COMPANY LIMITED Source text for Eikon: Further company coverage: (Gdynia Newsroom)

#jobs #lifescience Director of Accounting – Growing Pharmaceutical Company

// MA-Boston, Director of Accounting – Growing Pharmaceutical Company Director of Accounting – Growing Pharmaceutical Company *This position offers bonus, stock options, and a competitive ...

Disclosure of large shareholding

Dublin, Ireland, 13 June 2016: Reference is made to the stock exchange announcement made by Navamedic ASA ("NAVA" or the "Company") earlier today regarding the Company enter...

La Jolla Pharmaceutical Company Announces Agreement with European Medicines Agency on Pivotal Study of LJPC-401

-Conference Call at 9:00 AM Eastern Time on Thursday, September 8, 2016 La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapie...

Simavita Limited: Appointment of Company Secretary

SYDNEY, AUSTRALIA -- (Marketwired) -- 07/13/16 -- Simavita Limited ("Simavita" or the "Company") (TSX VENTURE: SV)(ASX: SVA) advises the appointment of Nathan Bartrop as Joint Company Secretary. Na...

Takeda Launches Largest Pharmaceutical Company-Sponsored Global Observational Study of Its Kind in Multiple Myeloma

Takeda Pharmaceutical Company Limited is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science i...

BRIEF-Sumitomo Dainippon readying new type of cancer treatment for release in fiscal 2017 - Nikkei

* Sumitomo Dainippon Pharma is readying new type of cancer treatment that targets culprit behind metastasis,recurrence for release in fiscal 2017-Nikkei

Navamedic ASA - Registration of share capital increase

Oslo, 17 June 2016. Reference is made to the stock exchange announcement made by Navamedic ASA ("NAVA" or the "Company") on 13 June 2016 regarding the Company entering i...

Drugs and Medications [0 Results]

None

PubMed Articles [496 Associated PubMed Articles listed on BioPortfolio]

Current Challenges and Potential Opportunities for the Pharmaceutical Sciences to Make Global Impact: An FIP Perspective.

The chairs of each of the 8 Special Interest Groups of the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation have compiled opinions with regard to major challenges for th...

The History of Articulators: The Contributions of Rudolph L. Hanau and His Company-Part II.

This article is an historical overview of the Hanau Engineering Company from the time of Rudolph Hanau's death in 1930 to the present. It explores the development of many articulators intended both fo...

A Critical Analysis of Concentration and Competition in the Indian Pharmaceutical Market.

It can be argued that with several players marketing a large number of brands, the pharmaceutical market in India is competitive. However, the pharmaceutical market should not be studied as a single m...

Information flow in the pharmaceutical supply chain.

Managing the supply chain plays an important role in creating competitive advantages for companies. Adequate information flow in supply chain is one of the most important issues in SCM. Therefore, usi...

Pharmaceutical Lore in the Lapidary of Sidrac (13th century).

Clinical Trials [25 Associated Clinical Trials listed on BioPortfolio]

Pharmacotherapy Follow-up in Older HIV-infected Patients

Cardiovascular diseases (CVD) are the main cause of death in Spain. In HIV patients, the uncontrolled viral replication, antiretroviral therapy (ART) and coinfections contribute to develop...

Randomized Crossover Trial for the Evaluation of the Possible Effects in the Intestine of Two Different Pharmaceutical Forms of L - Thyroxine in Patients With Primary Acquired Hypothyroidism

Thyroid disorders, in particular hypothyroidism, are associated with gastrointestinal impairment, such as celiac disease. A study reported an increased prevalence of celiac disease in a la...

Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Pharmaceutical Industry (IDI), Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Prodactariv 60 mg F.C.T (International Drug Agency for Pha...

Single and Repeated Dose Escalation Study of GSK2838232

GSK2838232 is a Human Immunodeficiency Virus (HIV) maturation inhibitor being developed for the treatment of HIV in combination with other antiretroviral therapy (ART). The primary objecti...

Nanoparticles Emitted by Aircraft Engines, Impact on the Respiratory Function:

The object of this new project is to proceed with investigations with the employees of the cohort for the first study so as to obtain a remote evolution (5 years) of their respiratory func...

Companies [5 Associated Companies listed on BioPortfolio]

Dainippon Sumitomo Pharma Co., Ltd.

Dainippon Sumitomo Pharma Co., Ltd., (DSP), is a top-ten listed pharmaceutical company in Japan with a diverse portfolio of pharmaceutical, animal health and food and specialty products. DSP's strong...

Dainippon Sumitomo Pharma America, Inc.

Dainippon Sumitomo Pharma America, Inc. (DSPA) located in Fort Lee, N.J., is a subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP). On April 1, 2010, DSP's two North American operations - DSPA and...

Dainippon Pharmaceutical Company Limited

Antibiotics Diagnostics Veterinary

Chelsea Therapeutics International, Ltd.

Chelsea Therapeutics (Nasdaq:CHTP) is a biopharmaceutical development company that acquires, develops and commercializes innovative products for the treatment of a variety of huma...

Sepracor Inc.

Sepracor Inc., an indirect, wholly-owned subsidiary of Dainippon Sumitomo Pharma Co., Ltd., is a research-based pharmaceutical company dedicated to treating and preventing human d...

More Information about "Dainippon Pharmaceutical Company Limited" on BioPortfolio

We have published hundreds of Dainippon Pharmaceutical Company Limited news stories on BioPortfolio along with dozens of Dainippon Pharmaceutical Company Limited Clinical Trials and PubMed Articles about Dainippon Pharmaceutical Company Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dainippon Pharmaceutical Company Limited Companies in our database. You can also find out about relevant Dainippon Pharmaceutical Company Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record